Pharmacogenomic Testing to Select Antiplatelet Therapy

被引：9
|
作者：
Price, Matthew J. [1 ]
Angiolillo, Dominick J. [2 ]
机构：
[1] Scripps Clin, Div Cardiovasc Dis, 9898 Genesee Ave,AMP 200, La Jolla, CA 92037 USA
[2] Univ Florida, Div Cardiol, Jacksonville, FL USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 17期
关键词：
acute coronary syndrome; antiplatelet therapy; clopidogrel; pharmacogenomics; platelet function testing; platelet reactivity; prasugrel; thienopyridine; ticagrelor; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; DOSE CLOPIDOGREL; GENETIC POLYMORPHISMS; CLINICAL-OUTCOMES; RANDOMIZED-TRIAL; TICAGRELOR; PRASUGREL; STANDARD; IMPLANTATION;
D O I：
10.1016/j.jacc.2018.03.021
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1878 / 1881
页数：4
相关论文
共 50 条
  • [41] Review and consensus on pharmacogenomic testing in psychiatry
    Faiz, Mark
    Ahmed, Sanjida
    PSYCHOLOGICAL MEDICINE, 2024, 54 (15) : 4456 - 4456
  • [42] A brighter future for the implementation of pharmacogenomic testing
    van der Wouden, Cathelijne H.
    Swen, Jesse J.
    Samwald, Matthias
    Mitropoulou, Christina
    Schwab, Matthias
    Guchelaar, Henk-Jan
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2016, 24 (12) : 1658 - 1660
  • [43] Direct-to-consumer pharmacogenomic testing
    Howard, Heidi Carmen
    Borry, Pascal
    PHARMACOGENOMICS, 2011, 12 (10) : 1367 - 1370
  • [44] A brighter future for the implementation of pharmacogenomic testing
    Cathelijne H van der Wouden
    Jesse J Swen
    Matthias Samwald
    Christina Mitropoulou
    Matthias Schwab
    Henk-Jan Guchelaar
    European Journal of Human Genetics, 2016, 24 : 1658 - 1660
  • [45] Is There a Role for Platelet Function Testing for Patients on Chronic Dual Antiplatelet Therapy?
    Sutton J.J.
    Barker C.M.
    Current Cardiovascular Risk Reports, 2010, 4 (5) : 327 - 331
  • [46] The effect of antiplatelet therapy and oral anticoagulants on the accuracy of faecal immunochemical testing
    Wu, F.
    Khan, Aa
    Klimovskij, M.
    Harshen, R.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2024, 106 (06) : 521 - 527
  • [47] Warfarin and pharmacogenomic testing: The case for restraint
    Garcia, D. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 84 (03) : 303 - 305
  • [48] Preemptive Pharmacogenomic Testing in the Psychiatric Clinic
    Patrinosa, G. P.
    Skokou, M.
    Karaivazoglou, K.
    Ferentinos, P.
    Kalogeropoulou, M.
    Kolios, P.
    Gerasimou, H.
    Bali, P.
    Mitropoulos, K.
    Pagiati, S.
    Douzenis, A.
    Gourzis, F.
    Asimakopoulos, K.
    Tsermpini, E. E.
    PUBLIC HEALTH GENOMICS, 2018, 21 : 2 - 2
  • [49] Platelet function testing to time surgery in patients on dual antiplatelet therapy?
    Mahla, E.
    Raggam, R.
    Toller, W.
    HAMOSTASEOLOGIE, 2014, 34 (01): : 40 - 45
  • [50] Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection
    Sun, Christina N.
    Berenbrok, Lucas A.
    Stevenson, James M.
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 (05) : 769 - 769
12345